QVT Financial LP - TRACON PHARMACEUTICALS INC ownership

TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H100. A total of 27 filers reported holding TRACON PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
QVT Financial LP ownership history of TRACON PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2018$15,000
-68.8%
23,3510.0%0.01%
-58.3%
Q3 2018$48,000
-23.8%
23,3510.0%0.01%
-33.3%
Q2 2018$63,000
-38.2%
23,351
-49.1%
0.02%
+63.6%
Q1 2018$102,000
-74.3%
45,869
-63.3%
0.01%
-50.0%
Q4 2017$397,000
-56.7%
124,966
-59.5%
0.02%
-35.3%
Q3 2017$916,000
+12.4%
308,227
-9.2%
0.03%
+54.5%
Q2 2017$815,000
-36.0%
339,5390.0%0.02%
-45.0%
Q1 2017$1,273,000
-25.6%
339,539
-11.0%
0.04%
-23.1%
Q4 2016$1,711,000
-15.0%
381,477
+14.1%
0.05%
-31.6%
Q3 2016$2,014,000
+42.7%
334,206
-8.0%
0.08%
-21.6%
Q2 2016$1,411,000
-38.8%
363,2920.0%0.10%
-31.2%
Q1 2016$2,306,000
-31.3%
363,2920.0%0.14%
-25.0%
Q4 2015$3,357,000
-5.4%
363,2920.0%0.19%
+54.1%
Q3 2015$3,549,000
-13.5%
363,292
-1.4%
0.12%
+96.8%
Q2 2015$4,104,000
-17.9%
368,3300.0%0.06%
-77.7%
Q1 2015$5,001,000368,3300.28%
Other shareholders
TRACON PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
683 Capital Management, LLC 995,000$3,134,0000.33%
NEA Management Company, LLC 2,759,217$8,692,0000.30%
Eventide Asset Management 900,000$2,835,0000.16%
QVT Financial LP 308,227$916,0000.03%
Candriam S.C.A. 143,000$450,0000.01%
Virtu Financial LLC 23,684$75,0000.00%
TWO SIGMA SECURITIES, LLC 13,352$42,0000.00%
BLUESTEIN R H & CO LLC 16,000$50,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 54,135$171,0000.00%
Alyeska Investment Group, L.P. 97,676$308,0000.00%
View complete list of TRACON PHARMACEUTICALS INC shareholders